Long COVID is an often debilitating illness that occurs in at least 10% of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms …

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggered the
global coronavirus disease 2019 (COVID-19) pandemic. Although most infections cause a …

BACKGROUND The presence and reactivation of chronic viral infections, such as EBV,
CMV, and HIV, have been proposed as potential contributors to long COVID (LC), but …

Cognitive dysfunction is often reported in patients with post-coronavirus disease 2019
(COVID-19) syndrome, but its underlying mechanisms are not completely understood …

Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

Alzheimer's disease (AD) and COVID-19 share many common risk factors, such as
advanced age, complications, APOE genotype, etc. Epidemiological studies have also …

Objective Transcranial magnetic stimulation (TMS) studies showed that patients with
cognitive dysfunction and fatigue after COVID-19 exhibit impaired cortical GABA B-ergic …

Although neurological complications of SARS-CoV-2 infection are relatively rare, their
potential long term morbidity and mortality have a significant impact, given the large …

Long COVID, also known as post–COVID-19 condition (PCC), refers to a range of symptoms
that may persist for weeks to months after acute COVID-19. A subset of people with PCC …

Background The burden and duration of persistent symptoms after nonsevere coronavirus
disease 2019 (COVID-19) remains uncertain. This study aimed to assess postinfection …